Fort, L.P. Vertex Pharmaceuticals Inc Transaction History

Fort, L.P.

$38.5 Million
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$392.81 - $485.53 $58,528 - $72,343	-149 Reduced 23.5%	485 $227,000
Q1 2024 May 14, 2024	SELL	$407.69 - $446.08 $80,722 - $88,323	-198 Reduced 23.8%	634 $265,000
Q3 2023 Nov 13, 2023	SELL	$338.18 - $362.46 $12,512 - $13,411	-37 Reduced 4.26%	832 $289,000
Q2 2023 Aug 11, 2023	SELL	$314.42 - $351.91 $43,075 - $48,211	-137 Reduced 13.62%	869 $305,000
Q1 2023 May 12, 2023	SELL	$283.23 - $323.1 $141,898 - $161,873	-501 Reduced 33.24%	1,006 $316,000
Q4 2022 Feb 13, 2023	SELL	$285.76 - $321.48 $164,026 - $184,529	-574 Reduced 27.58%	1,507 $435,000
Q3 2022 Nov 10, 2022	SELL	$273.83 - $305.53 $212,765 - $237,396	-777 Reduced 27.19%	2,081 $603,000
Q2 2022 Aug 12, 2022	SELL	$234.96 - $292.55 $84,820 - $105,610	-361 Reduced 11.21%	2,858 $805,000
Q1 2022 May 13, 2022	SELL	$221.42 - $260.97 $15,277 - $18,006	-69 Reduced 2.1%	3,219 $840,000
Q4 2021 Feb 11, 2022	SELL	$177.01 - $223.45 $11,505 - $14,524	-65 Reduced 1.94%	3,288 $722,000
Q3 2021 Nov 12, 2021	SELL	$181.39 - $202.99 $302,558 - $338,587	-1,668 Reduced 33.22%	3,353 $608,000
Q2 2021 Aug 13, 2021	SELL	$187.49 - $221.1 $384,729 - $453,697	-2,052 Reduced 29.01%	5,021 $1.01 Million
Q1 2021 May 14, 2021	BUY	$207.02 - $241.31 $121,106 - $141,166	585 Added 9.02%	7,073 $1.52 Million
Q4 2020 Feb 12, 2021	BUY	$207.01 - $276.09 $492,683 - $657,094	2,380 Added 57.94%	6,488 $1.53 Million
Q3 2020 Nov 13, 2020	BUY	$255.65 - $303.1 $512,833 - $608,018	2,006 Added 95.43%	4,108 $1.12 Million
Q2 2020 Aug 13, 2020	SELL	$225.48 - $295.8 $462,910 - $607,277	-2,053 Reduced 49.41%	2,102 $610,000
Q1 2020 May 14, 2020	BUY	$199.77 - $247.81 $492,632 - $611,099	2,466 Added 146.0%	4,155 $989,000
Q4 2019 Feb 13, 2020	BUY	$166.71 - $223.91 $281,573 - $378,183	1,689 New	1,689 $370,000

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

Capital World Investors Los Angeles, CA

26.8M
Shares

$12.5 Billion
1.99% of portfolio
Vanguard Group Inc Valley Forge, PA

23.2M
Shares

$10.8 Billion
0.2% of portfolio
Black Rock Inc. New York, NY

21.3M
Shares

$9.9 Billion
0.23% of portfolio
State Street Corp Boston, MA

11.8M
Shares

$5.49 Billion
0.23% of portfolio
Capital Research Global Investors Los Angeles, CA

9M
Shares

$4.18 Billion
0.9% of portfolio

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fort, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Fort, L.P. with notifications on news.

Account